The B cell mutator AID promotes B lymphoid blast crisis and drug-resistance in chronic myeloid leukemia

Chronic myeloid leukemia (CML) is induced by BCR-ABL1 and can be effectively treated for many years with Imatinib until leukemia cells acquire drug resistance through BCR-ABL1 mutations and progress into fatal B lymphoid blast crisis (LBC). Despite its clinical significance, the mechanism of progres...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Klemm, Lars, Duy, Cihangir, Iacobucci, Ilaria, Kuchen, Stefan, von Levetzow, Gregor, Feldhahn, Niklas, Henke, Nadine, Li, Zhiyu, Hoffmann, Thomas K., Kim, Yong-mi, Hofmann, Wolf-Karsten, Jumaa, Hassan, Groffen, John, Heisterkamp, Nora, Martinelli, Giovanni, Lieber, Michael R, Casellas, Rafael, Müschen, Markus
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2931825/
https://ncbi.nlm.nih.gov/pubmed/19732723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2009.07.030
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares